BridgeBio Pharma, Inc. (BBIO)
75.64
+1.14
(+1.52%)
USD |
NASDAQ |
Dec 16, 16:00
75.95
+0.30
(+0.40%)
After-Hours: 20:00
BridgeBio Pharma Research and Development Expense (Annual): 506.46M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| Supernus Pharmaceuticals, Inc. | 106.36M |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |